in the series studied , 30 % of sera from advanced breast cancer patients contained elevated levels of the hmfg-i antigen as compared with 6 % of sera from healthy control women , whereas 53 % of the advanced breast cancer patients showed elevated levels of hmfg-2 antigen compared with 16,6 % of the controls .
C0006141
breast
C0006142
of the